Trials / Unknown
UnknownNCT05285397
Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.
Liraglutide's Effect on Weight Loss in Patients After Secondary Bariatric Surgery ; a Randomized Double-blind Controlled Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- General Committee of Teaching Hospitals and Institutes, Egypt · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Our primary objective is to assess the effect of Liraglutide on weight loss in patients who have undergone secondary bariatric surgeries. We set out to assess if Liraglutide is a viable option to augment weight loss in said category.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liraglutide Pen Injector [Saxenda] | Subcutaneous injection of GLP-1 agonist |
Timeline
- Start date
- 2022-03-10
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2022-03-17
- Last updated
- 2022-03-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05285397. Inclusion in this directory is not an endorsement.